Capital World Investors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,169
Closed -$3.51M 598
2025
Q2
$3.51M Buy
11,169
+7,554
+209% +$2.27M ﹤0.01% 525
2025
Q1
$1.1M Sell
3,615
-434,736
-99% -$146M ﹤0.01% 529
2024
Q4
$146M Sell
438,351
-14
-0% -$4.75K 0.02% 304
2024
Q3
$146M Buy
438,365
+437,750
+71,179% +$166M 0.02% 311
2024
Q2
$253K Buy
+615
New +$244K ﹤0.01% 531

Other funds holding MEDP

Capital World Investors's MEDP Position: Q3 2025 in Review

Capital World Investors sold out of Medpace (MEDP) in Q3 2025, closing a stake of 11,169 shares — an estimated $3.51M sold.

Capital World Investors first reported a position in MEDP in Q2 2024 and held it in 5 quarters. The position peaked at $146M in Q3 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Capital World Investors reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Capital World Investors sold 11,169 Medpace shares in Q3 2025, an estimated $3.51M.
  • Capital World Investors first reported a position in Medpace in Q2 2024 and held it in 5 quarters.
  • Capital World Investors's Medpace position peaked at $146M in Q3 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Capital World Investors's 13F filing for Q3 2025, filed 13 Nov 2025.